A detailed history of Wealth Trust Asset Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Wealth Trust Asset Management, LLC holds 6,486 shares of VKTX stock, worth $334,223. This represents 0.31% of its overall portfolio holdings.

Number of Shares
6,486
Previous 5,700 13.79%
Holding current value
$334,223
Previous $302,000 35.76%
% of portfolio
0.31%
Previous 0.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$49.84 - $70.47 $39,174 - $55,389
786 Added 13.79%
6,486 $410,000
Q2 2024

Aug 12, 2024

BUY
$47.39 - $80.2 $52,129 - $88,220
1,100 Added 23.91%
5,700 $302,000
Q1 2024

May 03, 2024

BUY
$17.4 - $94.5 $80,040 - $434,700
4,600 New
4,600 $377,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.95B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Wealth Trust Asset Management, LLC Portfolio

Follow Wealth Trust Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Trust Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Trust Asset Management, LLC with notifications on news.